Hospira
Latest Hospira News
-
FDA Efforts Reversal of Critical Cancer Drug Shortage
manufacturers APP Pharmaceuticals and Hospira Inc . announced at the press briefing the nationwide demand. Next week Hospira plans to release 34,000 vials the drug, Michael Ball, CEO of Hospira Inc ., told reporters at Tuesday
-
States: Death-Penalty Drug Scramble, Higher Cost
said it would discontinue production. Lake Forest, Ill.-based Hospira , which strongly opposed the drug's use in executions, stopped manufacturing it altogether. Hospira said it couldn't promise authorities in Italy, where the drug was
-
Chemo Drug Taxol Shortage Puts Cancer Patients at Risk
summer," said spokeswoman Denise Bradley. Dan Rosenberg, a spokesman for Hospira of Lake Forest, Ill., said he didn't "have a time frame" for when Hospira could deliver more medication to the marketplace, but it was working to help
-
APNewsBreak: Complaint Targets Ga. Execution Doc
said. Many of the nation's 34 death penalty states have scrambled to find a new supplier of sodium thiopental after Hospira Inc ., its sole manufacturer in the U.S., said in January it would no longer make the drug. Several states postponed
-
Hospitals Hunt Substitutes as Drug Shortages Rise
the transplant drug thiotepa. Affected companies say they're working hard to eliminate backlogs. For instance, Hospira Inc ., the largest maker of those injectable drugs, says it is increasing production capacity and working with FDA
-
Hospitals Hunt Substitutes as Drug Shortages Rise
the transplant drug thiotepa. Affected companies say they're working hard to eliminate backlogs. For instance, Hospira Inc ., the largest maker of those injectable drugs, says it is increasing production capacity and working with FDA
News
-
Shortage of Leukemia Drug Forcing Hospitals to Turn Some Patients Away
drug's three U.S. manufacturers, Hospira , said in a statement that its delays ingredient, cytarabine, from its supplier. Hospira and another manufacturer, APP, also the companies to ensure that happens. Hospira says it started shipping product last
-
Ohio Executes Convict Using Single Controversial Drug
protocols, in which an injection of sodium thiopental was used to deliver the final painless killshot. Drug manufacturer Hospira announced last month it would no longer make the sodium thiopental, following several months of delays in production. Shortly
-
States Depend on Unapproved Foreign Drugs for Executions
developed by Abbott Laboratories in the 1930s and produced until about 2004, when Abbott spun off a new company called Hospira Inc . Hospira announced in January 2010 that it would permanently discontinue production. As states run out of the drug, they
-
Texas Only Has Enough Lethal Injection Drugs to Execute 2 of 317 Death Row Inmates
like a permanent solution last week when Hospira , the company that manufactured sodium objections over its use in executions. " Hospira had intended to produce [sodium thiopental capital punishment in the United States, Hospira said in a statement. Hospira also said
-
SCOTUS Stays Execution, Then Reverses
a driving school and say they are unsure whether the drug is expired or even labeled properly. The only US manufacturer, Hospira , has announced it's halting production. Nearly all of the 39 states that permit lethal injection use sodium thiopental
-
Oklahoma Plans to Execute Convict Using Veterinary Drug
states that implement the death penalty by lethal injection are scrambling to determine alternative ways to kill convicts. Hospira , the maker of sodium thiopental, better known as Pentothal, has announced a suspension of production of the drug because
-
Death Row, Where Is Thy Sting? Lethal Injection Drug in Short Supply
by only one pharmaceutical company -- Hospira -- that actually opposes its use in lethal condone its use in capital punishment. " Hospira manufactures this product because it improves indicated for capital punishment, and Hospira does not support its use in this procedure





